Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat

Molecular Carcinogenesis - Tập 14 Số 1 - Trang 28-36 - 1995
Raymond S. Yeung1, Guang‐Hui Xiao2, Jeffrey I. Everitt3, Fang Jin2, Cheryl Lyn Walker4
1Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
2Division of Medical Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania
3Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina
4Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas

Tóm tắt

AbstractSomatic events leading to the inactivation of tumor suppressor genes often involve chromosomal alterations that can be detected as loss of heterozygosity(a). In the Eker rat, spontaneous tumors of the kidney, uterus, and spleen develop as a result of a germline mutation of the tuberous sclerosis 2(Tsc2) gene. We examined the pattern and frequency of LOH at the predisposing locus in 77 primary tumors and cell lines to gain an understanding of the role of Tsc2 allelic loss in the pathogenesis of Eker‐derived tumors. Although most renal and uterine tumors(primary and cell lines) displayed LOH, splenic hemangiosarcomas did not. Although the presence of normal tissue may account for some of this difference, the possibility exists that an alternative mechanism, such as subtle mutation or gene dosage effects, may be involved during splenic tumorigenesis. Northern analysis confirmed that LOH resulted in loss of the wild‐type transcripts for the Tsc2 gene. Thus, the inactivation of both alleles plays an important role in renal and uterine tumor development, in keeping with Knudson's two‐hit hypothesis. In addition, renal tumors that retained the wild‐type allele also did not express the normal transcript, suggesting that the remaining Tsc2alleles had acquired subtle mutations resulting in loss of gene function.© 1995 Wiley‐Liss, Inc

Từ khóa


Tài liệu tham khảo

10.1073/pnas.90.23.10914

10.1111/j.1699-0463.1954.tb00301.x

Eker R, 1981, Hereditary renal adenomas and adenocarcinomas in rats, Diagnostic Histopathology, 4, 99

10.1016/S0022-5347(17)37087-8

10.1073/pnas.90.1.327

EverittJL WolfDC HoweSR GoldsworthyTL WalkerC. Rodent model of reproductive tract leiomyomata: Clinical and pathologic features.Am J Pathol in press.

10.1126/science.1553556

Hino O, 1993, Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat, Cancer Res, 53, 5856

10.1073/pnas.91.24.11413

10.1038/ng0195-70

10.1016/0092-8674(93)90618-Z

HoweSR GohardisMM EverittJL GoldsworthyTL WolfDC WalkerC. Rodent model of reproductive tract leiomyomata: Establishment and characterization of tumor‐derived cell lines.Am J Pathol in press.

10.1073/pnas.90.17.8038

10.1021/bi00591a005

Walker C, 1992, Comparative Molecular Carcinogenesis, 289

Walker C, 1991, Altered expression of transforming growth factor‐a in hereditary rat renal cell carcinoma, Cancer Res, 51, 2973

10.1002/mc.2940040504

10.1002/mc.2940120408

10.1038/ng0294-193

10.1093/hmg/3.10.1833

Su L‐K, 1993, Association between wild type and mutant APC gene products, Cancer Res, 53, 2728

Fisher E, 1994, Human haploinsufficiency—one for sorrow, two for joy, Genet, 7, 5

Chang C‐Y, 1993, Quantitative effects of the retinoblastoma gene on mouse development and tissue‐specific tumorigenesis, Cell Growth Differ, 4, 1057

10.1016/0092-8674(91)90194-4